What is it about?
Most positive samples came from ICU, nephrology and urology. The most isolated bacteria were coagulase-negative staphylococci, Escherichia coli, and Staphylococcus aureus. All isolates showed a high resistance to most classes of antibiotics, staphylococci being susceptible to glycopeptides, oxazolidinones and glycylcyclines, and the enterobacteria to aminoglycosides and carbapenems. The resistance in non-fermentative bacilli exceeded 80% to most classes of antibiotics. The methicillin-resistance was 36% for coagulase-negative staphylococci and 82% for Staphylococcus aureus; the percentage of extended-spectrum beta-lactamase producing strains was 30%.
Featured Image
Photo by Landon Arnold on Unsplash
Why is it important?
The etiology of bacteremic syndromes is specifi c to the ward profi le, the Staphylococcus spp. being primarily isolated from wards where invasive procedures are frequently performed, while the enterobacteria from urology and nephrology wards. The level of antibiotic resistance is higher in surgery and ICU wards, with also higher percentage of resistance phenotypes than in medical wards.
Perspectives
Keywords: sepsis, blood cultures, blood culture contaminants, antibiotic susceptibility, resistance phenotypes
MD, BS, MHA, LLM, FAPSR, FCCP Petru Emil Muntean
European Respiratory Society
Read the Original
This page is a summary of: Etiology of Bacteremic Syndromes and Bacterial Susceptibility of Blood Culture Isolates in a Romanian County Hospital, Acta Medica Marisiensis, January 2014, De Gruyter Open Sp. z o.o.,
DOI: 10.2478/amma-2014-0018.
You can read the full text:
Resources
A 50-year-old male with fever, cough, dyspnoea, chest pain, weight loss and night sweats
A 50-year-old, male patient presented during the day for an urgent consultation. For over 10 weeks, he had had a history of high-grade fever (39°C), cough with mucopurulent expectoration, shortness of breath, right-sided chest pain, weight loss (>10%) and night sweats.
A Rare Case of a Tuberculosis Patient with Sarcoidosis
Sarcoidosis and tuberculosis are chronic diseases that rarely occur concomitantly. We present the case of a 39-year-old woman with microbiological confirmation of pulmonary tuberculosis and concomitant sarcoidosis. Four weeks after corticosteroid therapy for sarcoidosis was introduced we had positive findings of mycobacterium culture from bronchial aspirate. Based on these results, corticosteroid therapy was discontinued and the patient received anti-tuberculosis therapy for six months as required by the national guidelines. During this period, new nodes on face, nose, and ear appeared and the patient was diagnosed with skin sarcoidosis. The patient received colchicine and corticosteroids as per the national guidelines.
Clinical Aspects and Evolution under Current Treatments on Pulmonary Alveolar Phospholipoproteinosis Patients
PAS treatment
Contributors
The following have contributed to this page
